Connect
MJA
MJA

Anesthesia, analgesia and pain

Perspective

Calling time on the use of modified‐release opioids for acute pain

Pamela E Macintyre, Melissa A Jamcotchian and Jennifer A Stevens

Med J Aust 2024; 221 (6): 293-296 Free

Research

Outcomes for people admitted to Australian and New Zealand intensive care units with primary, exacerbating, or incidental SARS‐CoV‐2 infections, 2022–23: a retrospective analysis of ANZICS data

Alastair Brown, Andrew Udy, Martyn Kirk, Sonya Bennett, Shaila Chavan, Sue Huckson and David Pilcher

Med J Aust 2024; 221 (4): 209-216 Free

Research

The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis

Forrest C Koch, Jake Olivier, Jonathan Brett, Nicholas A Buckley, Natasa Gisev, Sallie Pearson and Benjamin Daniels

Med J Aust 2024; 220 (6): 315-322 Free

Letters

Inter‐hospital transfer and clinical outcomes for people with COVID‐19 admitted to intensive care units in Australia

Prashant Maan, Anup Bansal and Vineet Nayyar

Med J Aust 2024; 220 (4): 218-218 Free

Guideline summary

Patient blood management guideline for adults with critical bleeding

Biswadev Mitra, Margaret Jorgensen, Michael C Reade, Anastazia Keegan, Anthony Holley, Shannon Farmer, Nichole Harvey, James Winearls, Michael Parr and Craig J French, for the Clinical and Consumer Reference Group for the Update of Patient Blood Management Guidelines (Module 1: Critical Bleeding/Massive Transfusion)

Med J Aust 2024; 220 (4): 211-216 Free

Letters

Feasibility of organ donation following voluntary assisted dying in Australia: lessons from international practice

Johannes Mulder and Hans Sonneveld

Med J Aust 2024; 220 (3): 164-165

Perspective

Considerations of delayed gastric emptying with peri‐operative use of glucagon‐like peptide‐1 receptor agonists

Lisa M Raven, Campbell Brown and Jerry R Greenfield

Med J Aust 2024; 220 (1): 14-16 Free

Research

Organ donation by children in Australia, 2000–2019: impact of the 2009 National Reform Program. A population‐based registry data study

Tal T Klein, Michael J O'Leary, Lukas Staub and Elena Cavazzoni

Med J Aust 2023; 218 (11): 520-525 Free

Research

Mortality among people admitted to Australian intensive care units for reasons other than COVID‐19 during the COVID‐19 pandemic: a retrospective cohort study

Sing Chee Tan, Tess Evans, Matthew L Durie, Paul J Secombe and David Pilcher

Med J Aust 2023; 218 (10): 467-473 Free

Research

Inter‐hospital transfer and clinical outcomes for people with COVID‐19 admitted to intensive care units in Australia: an observational cohort study

Courtney Cini, Ary S Neto, Aidan Burrell and Andrew Udy, the SPRINT‐SARI Australia investigators

Med J Aust 2023; 218 (10): 474-481 Free

Editorials

Beyond the intensive care unit: ensuring the long term health of critically ill Indigenous people

Dianne P Stephens

Med J Aust 2023; 218 (2): 71-72 Free

Narrative review

The role of spinal surgery in the treatment of low back pain

Lachlan Evans, Thomas O’Donohoe, Andrew Morokoff and Katharine Drummond

Med J Aust 2023; 218 (1): 40-45 Free

Medical education / Snapshot

Tattoo sarcoidosis presenting as abdominal allodynia

Annabelle Faint and A James M Daveson

Med J Aust 2022; 217 (1): 23-23 Free

Medical education / Snapshot

Angiosarcoma presenting as unexplainable unilateral leg pain and purpuric toes

Genevieve Ho and Dedee F Murrell

Med J Aust 2021; 215 (10): 456-456

Letters

Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic

Rochelle Wynne, Caleb Ferguson and Patricia M Davidson

Med J Aust 2021; 215 (10): 485-485 Free

Letters

Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic

Aidan JC Burrell, Tessa Broadley and Andrew A Udy

Med J Aust 2021; 215 (10): 485-485 Free

Letters

Buprenorphine: extended‐release formulations “a game changer”!

Katerina Lagios

Med J Aust 2021; 214 (11): 534-534.e1

Editorials

The challenges of managing both chronic pain and opioid use in general practice

Hester Wilson

Med J Aust 2021; 214 (9): 416-417

Editorials

Lack of efficacy of cannabidiol for relieving back pain: time to re‐set expectations?

Chris Hayes and Jennifer H Martin

Med J Aust 2021; 214 (8): 360-361

Research letters

Opioid cessation is associated with reduced pain and improved function in people attending specialist chronic pain services

Hilarie Tardif, Christopher Hayes and Samuel F Allingham

Med J Aust 2021; 214 (9): 430-432 Free

Perspectives

Should we be routinely co‐prescribing naloxone for patients on long term opioids?

Pallavi Prathivadi and Suzanne Nielsen

Med J Aust 2021; 214 (9): 403-404.e1

Research

The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain

Bronwyn Bebee, David M Taylor, Elyssia Bourke, Kimberley Pollack, Lian Foster, Michael Ching and Anselm Wong

Med J Aust 2021; 214 (8): 370-375 Free

Systematic reviews

The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews

Christina Abdel Shaheed, Giovanni E Ferreira, Alissa Dmitritchenko, Andrew J McLachlan, Richard O Day, Bruno Saragiotto, Christine Lin, Vicki Langendyk, Fiona Stanaway, Jane Latimer, Steven Kamper, Hanan McLachlan, Harbeer Ahedi and Christopher G Maher

Med J Aust 2021; 214 (7): 324-331 Free

Letters

Palliative radiotherapy for bone metastases at the end of life in Victoria

Wee Loon Ong, Farshad Foroudi, Roger L Milne and Jeremy L Millar

Med J Aust 2021; 214 (5): 236-237.e1

Medical education / Lessons from practice

Pharmacovigilance for chlorhexidine anaphylaxis: a preventable adverse reaction

Suran L Fernando, Marc J Capon, Sarah L Green and Michael J Boyle

Med J Aust 2021; 214 (4): 162-163.e1